“Buy High, Sell Higher”: A Look At Shire plc, ITV plc, Sirius Minerals plc, Betfair Group Ltd & Oxford BioMedica plc

Shire plc (LON:SHP), ITV plc (LON:ITV), Sirius Minerals plc (LON:SXX), Betfair Group Ltd (LON:BET) and Oxford BioMedica plc (LON:OXB) are attractive momentum shares.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Market timing can be one of the most important aspects to consider when investing. “Buy low, sell high” is widely considered as the most simple rule to investing. But, should investors really buy shares that are trading near their historical lows, and then sell them when they are near their historical highs?

Over a century of empirical evidence suggests that this method of choosing shares is ill-conceived. Buying shares that are trading near their historical lows often leads to poor investment returns. Shares that have outperformed the market, or are trading near their historical highs, tend to also outperform poorly performing shares in the following months. This phenomenon is known as the “momentum effect”.

Although analysts are not entirely certain for why the momentum effect exists, there are many possible explanations. One reason could be that investors may have systemic upward biases for the earnings forecasts of underperforming shares, leading to a cycle of earnings disappointment and lower share prices. Another could be crowd behaviour, where fund managers follow one another to create a similar portfolio of assets, causing share prices to exhibit momentum.

“Buy high, sell higher” is the adage that investors would do well to remember. And here are attractive five momentum shares:

Shire

Shares in Shire (LSE: SHP) have risen 50% over the past year, and the company has a forward P/E of 21.1. The company has gone on an acquisition spree in recent years to bolster its pipeline of new treatments for rare diseases. Currently, Shire is looking at buying Actelion, a Swiss biotech firm, for a reported £12.4 billion.

Shire’s strong pipeline of new treatments for rare diseases should help it to deliver faster earnings growth than its big pharma rivals, including GlaxoSmithKline and AstraZeneca.

ITV

ITV (LSE: ITV) has been showing strong earnings momentum in recent years, with adjusted earnings having risen by 75% over the past four years. The company has recovered strongly since the recession, and is successfully growing its online, pay and interactive offerings, which saw revenues grow 30% in 2014. Its forward P/E is 17.0.

Sirius Minerals

Shares in Sirius Minerals (LSE: SXX) have risen by 79% over the past year, as the prospects of obtaining the necessary permits for its Yorkshire potash mining development seem increasingly promising. The prospective cost of production is expected to be as low as $30 per tonne, which compares favourably to the market price of potash of over $200 per tonne.

But, the company still needs to source more than £1.5 billion to fund development costs, when the project is finally approved. Investors will have a long wait before the company begins to return cash to shareholders.

Betfair

Although Betfair (LSE: BET) is better known for its betting exchange, its bookmaking business is doing much better in attracting new customers. The company has invested strongly in developing a competitive edge through product innovations, including in-game cash outs and “price rush”.

The bookmaker is set to announce its preliminary full year earnings on Wednesday 17 June. Currently, analysts expect adjusted earnings per share of 74.2 pence, with revenues of $471 million. This implies a forward P/E of 33.8.

Oxford BioMedica

Oxford BioMedica (LSE: OXB) is attractive because of its development collaboration deal with Novartis. Significant development revenues from Novartis could transform the company to become operationally cash flow positive by 2016. The company’s pipeline of gene and cell therapies are in the early stages of development, so investors in Oxford BioMedica may have a long wait.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has recommended shares in GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

2 FTSE income stocks investors should consider buying in April

Income stocks are a great way to build wealth. Our writer details two picks she believes investors should consider snapping…

Read more »

Investing Articles

What might the 5-year price chart tell us about BT shares?

Christopher Ruane considers what clues the long-term performance of BT shares might offer him about business performance and whether to…

Read more »